Targeted nanotheranostics for personalized cancer therapy

Author： Diou Odile   Tsapis Nicolas   Fattal Elias  

Publisher： Informa Healthcare

ISSN： 1742-5247

Source： Expert Opinion on Drug Delivery, Vol.9, Iss.12, 2012-12, pp. : 1475-1487

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cancer gene therapy with targeted adenoviruses

By Bachtarzi Houria   Stevenson Mark   Fisher Kerry  

Expert Opinion on Drug Delivery, Vol. 5, Iss. 11, 2008-11 ,pp. : 1231-1240

Informa Healthcare

Access to resources Recommend Favorite

Ligand-based targeted therapy for cancer tissue

By Das Manasi   Mohanty Chandana   Sahoo Sanjeeb K  

Expert Opinion on Drug Delivery, Vol. 6, Iss. 3, 2009-03 ,pp. : 285-304

Informa Healthcare

Access to resources Recommend Favorite

Antibody-targeted liposomes in cancer therapy and imaging

By Sofou Stavroula   Sgouros George  

Expert Opinion on Drug Delivery, Vol. 5, Iss. 2, 2008-02 ,pp. : 189-204

Informa Healthcare

Access to resources Recommend Favorite

Epithelial cell adhesion molecule-targeted drug delivery for cancer therapy

By Simon Manuel   Stefan Nikolas   Plückthun Andreas   Zangemeister-Wittke Uwe  

Expert Opinion on Drug Delivery, Vol. 10, Iss. 4, 2013-04 ,pp. : 451-468

Informa Healthcare

Access to resources Recommend Favorite

Tumor-targeted delivery of siRNA by non-viral vector: safe and effective cancer therapy

By Chen Yunching   Huang Leaf  

Expert Opinion on Drug Delivery, Vol. 5, Iss. 12, 2008-12 ,pp. : 1301-1311

Informa Healthcare

Access to resources Recommend Favorite